Are sample medicines hurting the uninsured?

J Am Board Fam Pract. Sep-Oct 2002;15(5):361-6.

Abstract

Background: Pharmaceutical representatives often give sample medications to physicians for distribution to patients. In chronic conditions such as hypertension, this practice can contribute to unnecessary medication changes, gaps in treatment, and inferior control of disease. The objective of the current study was to explore associations between use of free sample medicine, hypertension, and source of payment for health care.

Methods: Telephone interviews and chart reviews were conducted at two community health centers in California. Adults with hypertension who had at least three clinic visits in the previous year and either had no insurance or had Medicare or Medicaid were included.

Results: Seventy-one patients participated. Seventeen had received sample medicines up to three times within the previous year. Lack of insurance (P < .01) was associated with sample medicine use. No group differences were found for medication changes. In multiple regression analysis, uninsured patients who received sample medicines had higher diastolic blood pressure (P = .01).

Conclusions: Lack of insurance was the principle predictor of use of sample medications. Although cross-sectional design and covariance of independent variables limit conclusions, higher diastolic blood pressure was related to sample medication use in patients who did not have insurance.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antihypertensive Agents / economics
  • Antihypertensive Agents / therapeutic use
  • California
  • Cross-Sectional Studies
  • Data Collection / methods
  • Drug Prescriptions / economics*
  • Female
  • Health Services Accessibility / economics*
  • Humans
  • Hypertension / drug therapy
  • Hypertension / economics
  • Male
  • Medicaid
  • Medically Uninsured*
  • Medicare
  • Middle Aged
  • Practice Patterns, Physicians'*
  • Regression Analysis
  • United States

Substances

  • Antihypertensive Agents